Status:
COMPLETED
Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control
Lead Sponsor:
Washington University School of Medicine
Conditions:
Parkinson's Disease
Eligibility:
All Genders
Brief Summary
In this study, the investigators will follow patients who have had stimulators implanted, at their usual clinic follow-up appointments 3, 6, 9 and 12 months after surgery. It is typical at these appoi...
Eligibility Criteria
Inclusion
- Meet criteria for "definite" Parkinson's Disease (PD)
- STN stimulators on both sides (right and left)
- Surgery done at Washington University within 2 years
Exclusion
- Significant visual deficits (e.g. double vision, untreated eyelid apraxia, blepharospasm) Must be able to see screen
- Secondary Parkinsonism (drug-induced or other known etiologies)
- Brain injury or defect: history of serious head injury, stroke, encephalitis, defect found on brain imaging
- Early severe dementia (within first year of onset) or on cholinesterase inhibitors
- Pre-surgical Mini Mental Status exam score \< 24
- Significant current psychiatric diagnoses (such as depression or psychosis) or on neuroleptics
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00917722
Start Date
March 1 2006
End Date
December 1 2013
Last Update
November 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110